Article Details

Genetic testing company 23andMe rises in first trade after Richard Branson SPAC merger

Retrieved on: 2021-06-17 21:11:59

Tags for this article:

Click the tags to see associated articles and topics

Genetic testing company 23andMe rises in first trade after Richard Branson SPAC merger . View article details on hiswai:

Excerpt

23andMe, a genetic testing start-up that pioneered personalized medicine as a consumer business, trades under ticker "ME" in a deal with Richard Branson's SPAC.

Article found on: www.cnbc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo